Cargando…
Effects of gender affirming hormone therapy on body mass index in transgender individuals: A longitudinal cohort study
INTRODUCTION: Many transgender people take hormone therapy to affirm their gender identity. One potential long-term consequence of gender affirming hormone therapy is increased body mass index (BMI), which may be associated with metabolic syndrome, cardiovascular disease and higher mortality. Only a...
Autores principales: | Suppakitjanusant, Pichatorn, Ji, Yuhan, Stevenson, Mary O., Chantrapanichkul, Panicha, Sineath, R. Craig, Goodman, Michael, Alvarez, Jessica A., Tangpricha, Vin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358708/ https://www.ncbi.nlm.nih.gov/pubmed/32685379 http://dx.doi.org/10.1016/j.jcte.2020.100230 |
Ejemplares similares
-
Gender-affirming Hormone Therapy and Risk of Diabetes in Transgender Persons
por: Tangpricha, Vin
Publicado: (2022) -
Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy
por: Hashemi, Leila, et al.
Publicado: (2021) -
ODP425 Potassium Level Trends in Trans Females Using Spironolactone: A Retrospective Chart Review
por: Gupta, Pranav, et al.
Publicado: (2022) -
Use of Standardized Patients in Endocrinology Fellowship Programs to Teach Competent Transgender Care
por: Stevenson, Mary O, et al.
Publicado: (2019) -
Determinants of and Barriers to Hormonal and Surgical Treatment Receipt Among Transgender People
por: Sineath, R. Craig, et al.
Publicado: (2016)